Review: Thromboses among HIV-infected patients during the highly active antiretroviral therapy era

AIDS Patient Care and STDs

Volumn 22, Issue 10, 2008, Pages 771-778

  Crum Cianflone, Nancy F ^a,b   Weekes, Jhamillia ^a,b   Bavaro, Mary ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATAZANAVIR; CD4 ANTIGEN; CHOLESTEROL; DIDANOSINE; EMTRICITABINE; ERYTHROPOIETIN; HIGH DENSITY LIPOPROTEIN; INDINAVIR; INTERLEUKIN 1; INTERLEUKIN 6; LAMIVUDINE; LOPINAVIR; LOW DENSITY LIPOPROTEIN; MEGESTROL ACETATE; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTICOAGULANT THERAPY; COMORBIDITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMOGRAPHY; DISEASE DURATION; ENDOTHELIUM CELL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; INFLAMMATION; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; REVIEW; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; THROMBOSIS;

EID: 53849140799     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0010     Document Type: Review

References (94)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
2. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007;146:87-95.
3. Bonnet F, Lewden C, May T, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004;101:317-324.
4. Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34.
5. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005;6:99-106.
6. Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006;41:194-200.
7. Copur AS, Smith PR, Gomez V, Bergman M, Homel, P. HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDs 2002;16:205-209.
8. Majluf-Cruz A, Silva-Estrada M, Sanchez-Barboza R, et al. Venous thrombosis among patients with AIDS. Clin Appl Thromb Hemost 2004;10:19-25.
9. Sullivan PS, Dworkin MS, Jones JL, Hooper WC. Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project. AIDS 2000;14:321-324.
10. Jacobson MC, Dezube BJ, Aboulafia DM. Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: A case series. Clin Infect Dis 2004;39:1214-1222.
11. Micieli E, Dentali F, Giola M, Grossi P, Venco A, Ageno W. Venous and arterial thrombosis in patients with HIV infection. Blood Coagul Fibrinolysis 2007;18:259-263.
12. Saif MW, Greenberg B. HIV and thrombosis: A review. AIDS Patient Care STDs 2001;15;15-24
13. Sugerman RW, Church JA, Goldsmith JC, Ens GE. Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1996;15:106-111.
14. Feffer SE, Fox RL, Orsen MM, Harjai KJ, Glatt AE. Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South Med J 1995;88:1126-1130.
15. Canoso RT, Zon LI, Groopman JE. Anticardiolipin antibodies associated with HTLV-III infection. Br J Haematol 1987;65:495-498.
16. Stimmler MM, Quismorio FP, McGehee WG, Boylen T, Sharma OP. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 1989;149:1833-1835.
17. Bissuel F, Berruyer M, Causse X, Dechavanne M, Trepo C. Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr 1992;5:484-489.
18. Hassell KL, Kressin DC, Neumann A, Ellison R, Marlar RA. Correlation of antiphospholipid antibodies and protein S deficiency with thrombosis in HIV-infected men. Blood Coagulation Fibrinolysis 1994;5:455-462.
19. Erbe M, Rickerts V, Bauersachs RM, Lindhoff-Last E. Acquired protein C and protein S deficiency in HIV-infected patients. Clin Appl Thromb Hemost 2003;9:325-331.
20. Dillmon MS, Saag MS, Hamza SH, Adler BK, Marques MB. Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: Case reports and review of the literature. AIDS Res Hum Retroviruses 2005;21:753-756.
21. Koppel K, Bratt G, Schulman S, Bylund H, Sandstrom E. Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002;29:441-449.
22. Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood 1993;81:1801-1807.
23. Trotti R, Rondanelli M, Anesi A, Gabanti E, Brustia R, Minoli L. Increased erythrocyte glutathione peroxidase activity and serum tumor necrosis factor-+ in HIV-infected patients: Relationship to on-going prothrombotic state. J Hematother Stem Cell Res 2002;11:369-375.
24. Lafon ME, Steffan AM, Royer C, et al. HIV-1 infection induces functional alterations in human liver endothelial cells in primary culture. AIDS 1994;8:747-752.
25. Mu H, Chai H, Lin PH, Yao Q, Chen C. Current update on HIV-associated vascular disease and endothelial dysfunction. World J Surg 2007;31:632-643.
26. Saif MW, Bona R, Greenberg B. AIDS and thrombosis: Retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 2001;15:311-320.
27. Shen YM, Frenkel EP. Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost 2004;10:277-280.
28. Van Dam Mieras MC, Van Bruggemen CA, Muller AD, et al. Induction of endothelial cell procoagulant activity by cytomegalovirus infection. Thromb Res 1987;47:69-75.
29. Force L, Barrufet P, Herreras Z, Bolibar I. Deep venous thrombosis and megestrol in patients with HIV infection. AIDS 1999;13:1425-1426.
30. Pulik M, Lionnet F, Couderc LJ, et al. Thromboembolic disease and human immunodeficiency virus infection. Blood 1993;82:2931.
31. Koller E, Gibert C, Green L, Mann M, Bernstein B. Thrombotic ev ents associated with megestrol acetate in patients with AIDS cachexia. Nutrition 1999;15:294.
32. Carr A, Brown D, Cooper DA. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. AIDS 1997;11:1657-1658.
33. George SL, Swindells S, Knudson R, Stapleton JT. Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: Report of seven cases. Am J Med 1999;107:624-630.
34. DAD Study Group, Friis-M ller N, Reiss P, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007;356:1723-1735.
35. Periard D, Telenti A, Sudre P, et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. Swiss HIV Cohort Study. Circulation 1999;100:700-705.
36. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton J III. Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year population-based study. Arch Intern Med 1998;158:585-593.
37. Saber AA, Aboolian A, LaRaja RD, Baron H, Hanna K. HIV/AIDS and the risk of deep vein thrombosis: A study of 45 patients with lower extremity involvement. Am Surg 2001;67:645-647.
38. Louw S, Jacobson BF, Büller H. Human immunodeficiency virus infection and acute deep vein thromboses. Clin Appl Thromb Hemost 2008;14:352-355.
39. Dunn JP, Yamashita A, Kempen JH, Jabs DA. Retinal vascular occlusion in patients infected with human immunodeficiency virus. Retina 2005;25:759-766.
40. Fultz SL, McGinnis KA, Skanderson M, Ragni MV, Justice AC. Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. Am J Med 2004;116:420-423.
41. Duerksen DR, Ahmad A, Doweiko J, Bistrian BR, Mascioli EA. Risk of symptomatic central venous thrombotic complications in AIDS patients receiving home parenteral nutrition. J Parenter Enteral Nutr 1996;20:302.
42. Lijfering WM, Ten Kate MK, Sprenger HG, van der Meer J. Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy. J Thromb Haemost 2006;4:1928-1930.
43. Kaufmann T, Nisce LZ, Metroka C. Thromboembolism in AIDS-related Kaposi's sarcoma. JAMA 1991;266:2834.
44. Mansour AM, Li H, Segal EI. Picture resembling hemicentral retinal vein occlusion in the acqurired immunodeficiency syndrome: Is it related to cytomegalovirus? Ophthalmologica 1996;210:108-111.
45. Primo S. Central retinal vein occlusion in a young patient with seropositive syphilis. J Am Optom Assoc 1990;61:896-902.
46. Bagley PH, Scott DA, Smith LS, Schillaci RF. Cytomegalovirus infection, ascending myelitis, and pulmonary embolus. Ann Intern Med 1986;104:587.
47. Bloom EJ, Abrams DI, Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 1986;256:491-493.
48. Peterson P, Stahl-Bayliss CM. Cytomegalovirus thrombophlebitis after successful DHPG therapy. Ann Intern Med 1987;106:632-633.
49. Teich SA, Sonnabend J. Central retinal vein occlusion in a patient with AIDS. Arch Ophthalmol 1988;106:1508-1509.
50. Meyohas MC, Roullet E, Rouzioux C, et al. Cerebral venous thrombosis and dual primary infection with human immunodeficiency virus and cytomegalovirus. J Neurol Neurosurg Psychiatry 1989;52:1010-1011.
51. Cohen JR, Lackner R, Wenig P, Pillari G. Deep venous thrombosis in patients with AIDS. NY State J Med 1990;90:159-161.
52. Lafeuillade A, ALessi MC, Poizot-Martin I, et al. Protein S deficiency and HIV infection. New Engl J Med 1991;324:1220.
53. Jenkins RE, Peters BS, Pinching AJ. Thromboembolic disease in AIDS is associated with cytomegalovirus disease. AIDS 1991;5:1540-1543.
54. Pinilla J, Hill A. Thromboembolism associated with acquired immunodeficiency syndrome. Chest 1992;102:1634.
55. Becker DM, Saunders TJ, Wispelwey B, Schain DC. Case report: Venous thromboembolisn in AIDS. Am J Med Sci 1992;303:395-397.
56. Roberts SP, Haefs TM. Central retinal vein occlusion in a middle-aged adult with HIV infection. Optom Vis Sci 1992;69:567-569.
57. Goldsmith W, Buckner J. central retinal vein occlusion in an AIDS patient: a case report. South J Optom 1992;10:35-38.
58. Ismail Y, Nemechek PM, Arsura EL. A rare cause of visual loss in AIDS patients: Central retinal vein occlusion. Br J Ophthalmol 1993;77:600-601.
59. Doberson MJ, Kleinschmidt-DeMasters BK. Superior sagittal sinus thrombosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1994;118:844-846.
60. Bilgrami S, Cable R, Pisciotto P, Rowland F, Greenberg B. Fatal disseminated intravascular coagulation and pulmonary thrombosis following blood transfusion in a patient with severe autoimmune hemolytic anemia and human immunodeficiency virus infection. Transfusion 1994;34:248-252.
61. Smith KJ, Skelton HG, Yeager J, Wagner KF. Cutaneous thrombosis in human immunodeficiency virus-1 positive patients and cytomegalovirus viremia. Arch Dermatol 1995;131:357-358.
62. Bayer DD, Sorbello AF, Condoluci DV. Bilateral subclavian vein thrombosis in a patient with acquired immunodeficiency syndrome. J Am Osteopath Assoc 1995;95:276-277.
63. Friedman SM, Margo CE. Bilateral central retinal vein occlusions in a patient with acquired immunodeficiency syndrome. Clinicopathologic correlation. Arch Ophthalmol 1995;113:1184-1188.
64. Conway MD, Tong P, Olk RJ. Branch retinal artery occlusion (BRAO) combined with branch retinal vein occlusion (BRVO) and optic disc neovascularization associated with HIV and CMV retinitis. Intern Ophthalmol 1996;19:249-252.
65. Laing RB, Brettle RP, Leen CL. Venous thrombosis and HIV infection. Int J STD AIDS 1996;7:82-85.
66. Tanimowo M. Deep vein thrombosis as a manifestation of the acquired immunodeficiency syndrome? A case report. Centr Afric J Med 1996;42:327-328.
67. Park KL, Marx JL, Lopez PF, Rao NA. Noninfectious branch retinal vein occlusion in HIV-positive patients. Retina 1997;17:162-164.
68. Narayanan TS, Narawane NM, Phadke AY, Abraham P. Multiple abdominal venous thrombosis in HIV-seropositive patient. Indian J Gastroenterol 1998;17:105-106.
69. Vielhauer V, Schewe CK, Schlondorff D. Bilateral thrombosis of the internal jugular veins with spasmodic torticollis in a patient with acquired immunodeficiency syndrome and disseminated cytomegalovirus infection. J Infect 1998;37:90-91.
70. Saif MW. Thromboembolism associated with HIV infection: A case report and review of the literature. AIDS Read 2000;10;492-496
71. Wen F, Chen X, Liao R. Bilateral central retinal vein occlusions in a Chinese patient with HIV-infection. Int Ophthalmol 2001;24:173-175.
72. Turhal NS, Peters VB, Rand JH. Antiphospolipid syndrome in HIV infection - Report on four cases and review of the literature. J World Allergy Org 2001;13:268-271.
73. Soman R, Kanekar A. Jugular venous thrombosis in HIV-seropositive man. J Assoc Physicians India 2002;50:595.
74. Karim MS, Athar MK, Ghobrial MW. Superior sagittal sinus thrombosis and HIV. Ann Intern Med 2002;137:375.
75. de Gaetano Donati K, Tacconelli E, Scoppettuolo G, De Stefano V, Cauda R, Tumbarello M. Recurrent venous thrombosis in a patient with haemophilia A and HIV infection. Haematologica 2002;87:ECR04
76. Afsari K, Frank J, Vaksman Y, Nguyen TV. Intracranial venous sinus thrombosis complicating AIDS-associated nephropathy. AIDS Reader 2003;13:143-148.
77. Callens S, Florence E, Philippe M, Van Der Planken M, Colebunders R. Mixed arterial and venous thromboembolism in a person with HIV infection. Scand J Infect Dis 2003;35:907-908.
78. Shahnaz S, Parikh G, Opran A. Antiphospholipid antibody syndrome manifesting as a deep venous thrombosis and pulmonary embolism in a patient with HIV. Am J Med Sci 2004;327:231-232.
79. Asherson RA, Gomez-Puerta JA, Marinopoulos G. Recurrent pulmonary thromboembolism in a patient with systemic lupus erythematosus and HIV-1 infection associated with the presence of antibodies to prothrombin: A case report. Clin Infect Dis 2005;41:e89-92.
80. Soentjens P, Ostyn B, Van Outryve S, Ysebaert D, Vekemans M, Colebunders R. Portal vein thrombosis in a patient with HIV treated with a protease inhibitor-containing regimen. Acta Clin Belg 2006;61:24-29.
81. Cortez-Escalante JJ, Castro C, Romero GA, Matos L, Saif MW. Pulmonary thromboembolism in AIDS patient with chronic venous insufficiency, pulmonary tuberculosis and breast cancer: A case report and pathophysiology review. Rev Inst Med Trop Sao Paulo 2006;48:105-108.
82. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep vein thrombosis within a defined urban population. J Intern Med 1992;232:155-160.
83. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism, The Worcester DVT study. Arch Intern Med 1991;151:933-938.
84. Rosendaal FR. Thrombosis in the young: Epidemiology and risk factors, a focus on venous thrombosis. Thromb Haemost 1997;78:1-6.
85. Klein SK, Slim EJ, de Kruif MD, et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med 2005;63:129-136.
86. Wilkes MS, Fortin AH, Felix JC, Godwin TA, Thompson WG. Value of necropsy in acquired immunodeficiency syndrome. Lancet 1988;2:85-88
87. Afessa B, Green W, Chiao J, Frederick W. Pulmonary complications of HIV infection: Autopsy findings. Chest 1998;113:1225-1229
88. Vay† A, Mira Y, Ferrando F, et al. Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors. Br J Haematol 2002;118:255-259.
89. Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA. Progressive prothrombotic state in women with advancing HIV disease. J Acquir Immune Defic Syndr 2006;42:572-577.
90. Gervasoni C, Ridolfo AL, Vaccarezza M, et al. Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy. Clin Infect Dis 2002;35:1534-1540.
91. Laurence J, Mitra D, Steiner M, Staiano-Coico L, Jaffe E. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells.
92. Friedman HM. Infection of endothelial cells by common human viruses. Rev Infect Dis 1989;11:S700-704.
93. Delbos V, Abgueguen P, Chennebault JM, Fanello S, Pichard E. Acute cytomegalovirus infection and venous thrombosis: role of antiphospholipid antibodies. J Infect 2007;54:e47-50.
94. Youd P, Main J, Jackson E. Cytomegalovirus infection and thrombosis: A causative association? J Infect 2003;46:141-142.